About Chugai
Chugai's mission is to create innovative drugs
for the benefit of patients.
News ReleasesRSS
- May 10, 2021 Chugai Reached Agreement with Japanese Government regarding Investigational Antibody Cocktail (casirivimab and imdevimab) for COVID-19
- May 10, 2021 Chugai Discontinues Marketing of Photodynamic Diagnostic Agent "ALAGLIO® Divided Granules 1.5g"
- May 06, 2021 Research Collaboration by Chugai, the University of Tokyo and RIKEN on Functional Genome Database Published in Cell
- Apr 26, 2021 CHMP Recommends EU Approval of Chugai’s Enspryng (Satralizumab) for Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Apr 22, 2021 Chugai Announces 2021 1st Quarter Results
-
Human Resources and Diversity & Inclusion
Find information on our initiatives to promote work-life balance and diverse human resources, and performance data for topics such as the ratio of female employees.
-
Personnel Systems
Chugai promotes engagement with employees by conducting talent management according to each person’s capabilities and aptitude, providing systems that help our diverse people to succeed, and creating supportive work environments.
For more information
Feature: Chugai’s Sustainability Activities
Recent Social Contribution Activities
-
Wheelchair Softball Trail Session
-
Contribution to Global Environmental Protection - Efforts to protect water resources through forest maintenance at our production site -
-
Workshop on Multidisciplinary Team Care in Cambodia
